504 related articles for article (PubMed ID: 20071495)
1. Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.
Sullivan KM; Spooner LM
Ann Pharmacother; 2010 Feb; 44(2):352-9. PubMed ID: 20071495
[TBL] [Abstract][Full Text] [Related]
2. Fidaxomicin for the treatment of Clostridium difficile infections.
Whitman CB; Czosnowski QA
Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
[TBL] [Abstract][Full Text] [Related]
3. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
4. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
Miller M
Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
[TBL] [Abstract][Full Text] [Related]
5. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
7. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Crawford T; Huesgen E; Danziger L
Am J Health Syst Pharm; 2012 Jun; 69(11):933-43. PubMed ID: 22610025
[TBL] [Abstract][Full Text] [Related]
8. Fidaxomicin: first-in-class macrocyclic antibiotic.
Mullane KM; Gorbach S
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):767-77. PubMed ID: 21810048
[TBL] [Abstract][Full Text] [Related]
9. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Hardesty JS; Juang P
Pharmacotherapy; 2011 Sep; 31(9):877-86. PubMed ID: 21923589
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Cornely OA
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
[TBL] [Abstract][Full Text] [Related]
11. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
13. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection.
Louie TJ; Emery J; Krulicki W; Byrne B; Mah M
Antimicrob Agents Chemother; 2009 Jan; 53(1):261-3. PubMed ID: 18955523
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.
Louie T; Miller M; Donskey C; Mullane K; Goldstein EJ
Antimicrob Agents Chemother; 2009 Jan; 53(1):223-8. PubMed ID: 18955525
[TBL] [Abstract][Full Text] [Related]
15. Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection.
Zhanel GG; Walkty AJ; Karlowsky JA
Can J Infect Dis Med Microbiol; 2015; 26(6):305-12. PubMed ID: 26744587
[TBL] [Abstract][Full Text] [Related]
16. Role of fidaxomicin for the treatment of Clostridium difficile infection.
Juang P; Hardesty JS
J Pharm Pract; 2013 Oct; 26(5):491-7. PubMed ID: 24064437
[TBL] [Abstract][Full Text] [Related]
17. Alternative therapies for Clostridium difficile infections.
Venuto C; Butler M; Ashley ED; Brown J
Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394
[TBL] [Abstract][Full Text] [Related]
18. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
Venugopal AA; Johnson S
Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of OPT-80 against Clostridium difficile.
Ackermann G; Löffler B; Adler D; Rodloff AC
Antimicrob Agents Chemother; 2004 Jun; 48(6):2280-2. PubMed ID: 15155234
[TBL] [Abstract][Full Text] [Related]
20. Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.
Morrow T
Manag Care; 2011 Jul; 20(7):49-50. PubMed ID: 21848202
[No Abstract] [Full Text] [Related]
[Next] [New Search]